Skip to main content
Clinical Trials/NCT01859091
NCT01859091
Completed
Not Applicable

Pilot Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area Using Cryolipolysis

Zeltiq Aesthetics1 site in 1 country14 target enrollmentOctober 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Fat Disorder
Sponsor
Zeltiq Aesthetics
Enrollment
14
Locations
1
Primary Endpoint
Number of Participants With Device and/or Procedure Related Adverse Events (AEs) and Device-related Serious Adverse Events (SADEs)
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

The purpose of this study is to evaluate the safety and feasibility of cryolipolysis for non-invasive reduction of submental fat.

Registry
clinicaltrials.gov
Start Date
October 1, 2013
End Date
October 1, 2014
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zeltiq Aesthetics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of Participants With Device and/or Procedure Related Adverse Events (AEs) and Device-related Serious Adverse Events (SADEs)

Time Frame: 8-weeks post treatment

An AE was any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in participants, whether or not considered related to treatment. A serious adverse event (SAE) was an AE that resulted in death, serious deterioration in health, permanent impairment of a body structure/function, was life-threatening, required hospitalization or medical/surgical intervention, led to fetal distress or death, congenital abnormality, or birth defect. An ADE was any sign, symptom, or disease that was determined by the Investigator to have a causal relationship or possible causal relationship with the investigational device, including any AE resulting from insufficient or inadequate instructions for use, deployment, implantation, installation, or operation, or any malfunction of the device or from use error or intentional misuse of the device. A SADE was an ADE that resulted in any of the consequences characteristic of an SAE.

Secondary Outcomes

  • Change in the Fat Layer of the Treated Area as Measured by Ultrasound(Baseline, 8-weeks post treatment)
  • Number of Pre- and Post-Treatment Photograph Pair Reviews (Correctly Identified by an Internal Reviewer Panel of 4 Reviewers)(8-weeks post treatment)

Study Sites (1)

Loading locations...

Similar Trials